Low expression of GRM4 is associated with poor prognosis and tumor immune infiltration in glioma

References

• Xu S, Tang L, Li X, et al. Immunotherapy for glioma: current management and future application. Cancer Lett. 2020;476(2020):1–12. doi:10.1016/j.canlet.2020.02.002.
   PubMedGoogle Scholar
• Louis DN, Perry A, Reifenberger G, et al. The 2016 world health organization classification of tumors of the Central nervous system: a summary. Acta Neuropathol. 2016;131(6):803–820. doi:10.1007/s00401-016-1545-1.
   PubMed Web of Science ®Google Scholar
• Chang HJ, Burke AE, Glass RM. JAMA patient page. Gliomas JAMA. 2010;303(10):1000. doi:10.1001/jama.303.10.1000.
   PubMedGoogle Scholar
• Gittleman H, Boscia A, Ostrom QT, et al. Survivorship in adults with malignant brain and other Central nervous system tumor from 2000-2014. Neuro Oncol. 2018;20(suppl_7):vii6–vii16. doi:10.1093/neuonc/noy090.
   PubMedGoogle Scholar
• Korja M, Raj R, Seppä K, et al. Glioblastoma survival is improving despite increasing incidence rates: a nationwide study between 2000 and 2013 in Finland. Neuro Oncol. 2019;21(3):370–379. doi:10.1093/neuonc/noy164.
   PubMed Web of Science ®Google Scholar
• Miranda-Filho A, Pineros M, Soerjomataram I, et al. Cancers of the brain and CNS: global patterns and trends in incidence. Neuro Oncol. 2017;19(2):270–280.
   PubMed Web of Science ®Google Scholar
• Weller M, Pfister SM, Wick W, et al. Molecular neuro-oncology in clinical practice: a new horizon. Lancet Oncol. 2013;14(9):e370–e9. doi:10.1016/S1470-2045(13)70168-2.
   PubMed Web of Science ®Google Scholar
• Julio-Pieper M, Flor PJ, Dinan TG, et al. Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues. Pharmacol Rev. 2011;63(1):35–58. doi:10.1124/pr.110.004036.
   PubMed Web of Science ®Google Scholar
• Suh Y H, Chang K, Roche KW. Metabotropic glutamate receptor trafficking. Mol Cell Neurosci. 2018;91:10–24. doi:10.1016/j.mcn.2018.03.014.
   PubMed Web of Science ®Google Scholar
• Wan Z, Sun R, Yang-Wuyue LIU, et al. Targeting metabotropic glutamate receptor 4 for cancer immunotherapy. Sci Adv. 2021;7(50):eabj4226. doi:10.1126/sciadv.abj4226.
   PubMed Web of Science ®Google Scholar
• Chang HJ, Yoo BC, Lim S-B, et al. Metabotropic glutamate receptor 4 expression in colorectal carcinoma and its prognostic significance. Clin Cancer Res. 2005;11(9):3288–3295. doi:10.1158/1078-0432.CCR-04-1912.
   PubMed Web of Science ®Google Scholar
• Kansara MAYA, Thomson K, Pang P, et al. Infiltrating myeloid cells drive osteosarcoma progression via GRM4 regulation of IL23. Cancer Discov. 2019;9(11):1511–1519. doi:10.1158/2159-8290.CD-19-0154.
   PubMed Web of Science ®Google Scholar
• Xiao B, Chen D, Zhou Q, et al. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p. BMC Cancer. 2019;19(1):891. doi:10.1186/s12885-019-6068-4.
   PubMed Web of Science ®Google Scholar
• Huang CY, Hsueh YM, Chen LC, et al. Clinical significance of glutamate metabotropic receptors in renal cell carcinoma risk and survival. Cancer Med. 2018;7(12):6104–6111. doi:10.1002/cam4.1901.
   PubMed Web of Science ®Google Scholar
• Takano T, Lin JH, Arcuino G, et al. Glutamate release promotes growth of malignant gliomas. Nat Med. 2001;7(9):1010–1015. doi:10.1038/nm0901-1010.
   PubMed Web of Science ®Google Scholar
• Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 2017;45(W1):W98–W102. doi:10.1093/nar/gkx247.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Zhang KN, Wang Q, et al. Chinese glioma genome atlas (CGGA): a comprehensive resource with functional genomic data from chinese glioma patients. Genomics Proteomics Bioinformatics. 2021;19(1):1–12. doi:10.1016/j.gpb.2020.10.005.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Lyon D, et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607–D613. doi:10.1093/nar/gky1131.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Gable AL, Nastou KC, et al. The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets. Nucleic Acids Res. 2021;49(D1):D605–D612. doi:10.1093/nar/gkaa1074.
   PubMed Web of Science ®Google Scholar
• Li T, Fu J, Zeng Z, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509–W514. doi:10.1093/nar/gkaa407.
   PubMed Web of Science ®Google Scholar
• Darmanis S, Sloan SA, Croote D, et al. Single-Cell RNA-Seq analysis of infiltrating neoplastic cells at the migrating front of human glioblastoma. Cell Rep. 2017;21(5):1399–1410. doi:10.1016/j.celrep.2017.10.030.
   PubMed Web of Science ®Google Scholar
• Patel AP, Tirosh I, Trombetta JJ, et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science. 2014;344(6190):1396–1401. doi:10.1126/science.1254257.
   PubMed Web of Science ®Google Scholar
• Balachandran VP, Gonen M, Smith JJ, et al. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–e80. doi:10.1016/S1470-2045(14)71116-7.
   PubMed Web of Science ®Google Scholar
• Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol. 2009;4(1):199–227. (doi:10.1146/annurev.pathol.4.110807.092222.
   PubMed Web of Science ®Google Scholar
• Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120(1):15–20. doi:10.1016/j.cell.2004.12.035.
   PubMed Web of Science ®Google Scholar
• Karagkouni D, Paraskevopoulou MD, Chatzopoulos S, et al. DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions. Nucleic Acids Res. 2018;46(D1):D239–D245. doi:10.1093/nar/gkx1141.
   PubMed Web of Science ®Google Scholar
• Chen Y, Wang X. miRDB: an online database for prediction of functional microRNA targets. [Nucleic Acids Res. 2020;48(D1):D127–D131. doi:10.1093/nar/gkz757.
   PubMed Web of Science ®Google Scholar
• Li JH, Liu S, Zhou H, et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92–7. doi:10.1093/nar/gkt1248.
   PubMed Web of Science ®Google Scholar
• Vasaikar SV, Straub P, Wang J, et al. LinkedOmics: analyzing multi-omics data within and across 32 cancer types. Nucleic Acids Res. 2018;46(D1):D956–D963. doi:10.1093/nar/gkx1090.
   PubMed Web of Science ®Google Scholar
• Robertson KD, Jones PA. DNA methylation: past, present and future directions. Carcinogenesis. 2000;21(3):461–467. doi:10.1093/carcin/21.3.461.
   PubMed Web of Science ®Google Scholar
• Modhukur V, Iljasenko T, Metsalu T, et al. MethSurv: a web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics. 2018;10(3):277–288. doi:10.2217/epi-2017-0118.
   PubMed Web of Science ®Google Scholar
• Koch A, DE Meyer T, Jeschke J, et al. MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data. BMC Genomics. 2015;16(1):636. (doi:10.1186/s12864-015-1847-z.
   PubMed Web of Science ®Google Scholar
• Koch A, Jeschke J, VAN Criekinge W, et al. MEXPRESS update 2019. Nucleic Acids Res. 2019;47(W1):W561–W565. doi:10.1093/nar/gkz445.
   PubMed Web of Science ®Google Scholar
• Yan D, Li W, Liu Q, et al. Advances in immune microenvironment and immunotherapy of isocitrate dehydrogenase mutated glioma. Front Immunol. 2022;13(7):914618. doi:10.3389/fimmu.2022.914618.
   PubMedGoogle Scholar
• Li B, Severson E, Pignon JC, et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016;17(1):174. doi:10.1186/s13059-016-1028-7.
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-Infiltrating immune cells. Cancer Res. 2017;77(21):e108-e10–e110. doi:10.1158/0008-5472.CAN-17-0307.
   Web of Science ®Google Scholar
• Berthele A, Platzer S, Laurie DJ, et al. Expression of metabotropic glutamate receptor subtype mRNA (mGluR1-8) in human cerebellum. Neuroreport. 1999;10(18):3861–3867. doi:10.1097/00001756-199912160-00026.
   PubMed Web of Science ®Google Scholar
• Miller S, Kesslak JP, Romano C, et al. Roles of metabotropic glutamate receptors in brain plasticity and pathology. Ann N Y Acad Sci. 1995;757(1):460–474. (doi:10.1111/j.1749-6632.1995.tb17506.x.
   PubMedGoogle Scholar
• Borodezt K, D’mello SR. Decreased expression of the metabotropic glutamate receptor-4 gene is associated with neuronal apoptosis. J. Neurosci. Res. 1998;53(5):531–541. doi:10.1002/(SICI)1097-4547(19980901)53:5<531::AID-JNR3>3.0.CO;2-A.
   PubMed Web of Science ®Google Scholar
• Lopez JP, Lim R, Cruceanu C, et al. miR-1202 is a primate-specific and brain-enriched microRNA involved in major depression and antidepressant treatment. Nat Med. 2014;20(7):764–768. doi:10.1038/nm.3582.
   PubMed Web of Science ®Google Scholar
• Li J, Meng H, Cao W, et al. MiR-335 is involved in major depression disorder and antidepressant treatment through targeting GRM4. Neurosci Lett. 2015;606:167–172. doi:10.1016/j.neulet.2015.08.038.
   PubMed Web of Science ®Google Scholar
• Zheng Y, Xie M, Zhang N, et al. miR-1262 suppresses gastric cardia adenocarcinoma via targeting oncogene ULK1. J Cancer. 2021;12(4):1231–1239. doi:10.7150/jca.46971.
   PubMed Web of Science ®Google Scholar
• Li L, Qu WH, Ma HP, et al. LRP8, modulated by miR-1262, promotes tumour progression and forecasts the prognosis of patients in breast cancer. Arch Physiol Biochem. 2022;128(3):657–665. doi:10.1080/13813455.2020.1716019.
   PubMed Web of Science ®Google Scholar
• Xie K, Chen M, Zhu M, et al. A polymorphism in miR-1262 regulatory region confers the risk of lung cancer in chinese population. Int J Cancer. 2017;141(5):958–966. doi:10.1002/ijc.30788.
   PubMed Web of Science ®Google Scholar
• Stadler F, Kolb G, Rubusch L, et al. Histone methylation at gene promoters is associated with developmental regulation and region-specific expression of ionotropic and metabotropic glutamate receptors in human brain. J Neurochem. 2005;94(2):324–336. doi:10.1111/j.1471-4159.2005.03190.x.
   PubMed Web of Science ®Google Scholar
• Fallarino F, Volpi C, Fazio F, et al. Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains neuroinflammation. Nat Med. 2010;16(8):897–902. doi:10.1038/nm.2183.
   PubMed Web of Science ®Google Scholar
• Iacovelli L, Arcella A, Battaglia G, et al. Pharmacological activation of mGlu4 metabotropic glutamate receptors inhibits the growth of medulloblastomas. J Neurosci. 2006;26(32):8388–8397. doi:10.1523/JNEUROSCI.2285-06.2006.
   PubMed Web of Science ®Google Scholar